Healthcare & Life Sciences Private Equity Deal Tracker: Ampersand and GHO Acquire Avid Bioservices for $1.1 Billion

McGuireWoods LLP
Contact

Ampersand Capital Partners and GHO Capital Partners will acquire Avid Bioservices for approximately $1.1 billion, according to a news release.

Avid (NASDAQ: CDMO), formed in 2002 and based in Orange County, California, is a biologics contract development and manufacturing organization (CDMO) that provides services to biotechnology and pharmaceutical companies.

Ampersand, based in Wellesley, Mass., is a middle market private equity firm with a focus on growth equity investments in the healthcare sector within North America, Europe and the Asia–Pacific region. Founded in 1988, the firm typically pursues majority or minority positions in companies generating between $10 million and $200 million in revenue.

GHO, or Global Healthcare Opportunities, is a London-based specialist healthcare investor.

The transaction is expected to close in the first quarter of 2025.

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations. Attorney Advertising.

© McGuireWoods LLP

Written by:

McGuireWoods LLP
Contact
more
less

PUBLISH YOUR CONTENT ON JD SUPRA NOW

  • Increased visibility
  • Actionable analytics
  • Ongoing guidance

McGuireWoods LLP on:

Reporters on Deadline

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
Custom Email Digest
- hide
- hide